LEGAL INFORMATION

01 · Legal Notice

GENERAL TERMS OF USE

1.1 Site owner

This website is owned by DRAK-MA LLC, a Limited Liability Company formed under the laws of the State of Wyoming (United States), operating under the trade name DRAKGEN™. For any legal inquiry: legal@drak-ma.com.

1.2 Purpose

This site is informational and commercial in nature. It describes the buyer acquisition and qualification services DRAKGEN offers to mortgage intermediation firms in international markets.

1.3 Nature of the service

1.4 Intellectual and industrial property

The content of this site (text, design, DRAKGEN brand and logo) is owned by DRAK-MA LLC or used under license. Third-party marks and logos that may appear (Meta, Instagram, Facebook, YouTube, Google Calendar, HighLevel or leaddistro.io) belong to their respective owners and are cited nominatively; their presence does not imply any affiliation, sponsorship or endorsement unless expressly stated.

1.5 Liability and links

The site is provided "as is". DRAKGEN does not warrant uninterrupted availability or absence of errors, and is not responsible for the content of linked third-party sites. Use of the site implies acceptance of these terms.

02 · Terms & Conditions

SERVICE CONDITIONS

2.1 Services

DRAKGEN delivers qualified opportunities under two service plans: Lead Premium™ Plan (delivery of the qualified lead with a complete profile, with the CLIENT handling first contact) and Confirmed Meeting™ Plan (DRAKGEN performs the confirmation call, phone re-qualification and booking on the CLIENT's calendar). Both plans are contracted through prepaid volume packs (50, 75, 100, 250, 500 or 1,000 units) or through the 30-unit Starter Pack™. The per-unit price is determined by the plan and pack contracted. There are no commissions on closed transactions, no revenue share and no lock-in periods.

2.2 Geographic exclusivity

DRAKGEN works with a single intermediation firm per geographic area. No opportunity captured in the client's assigned area is delivered to a third party during the term of the agreement.

2.3 Pricing and billing

The client pays exclusively per unit delivered. There are no lock-in periods, no commissions on closed deals, and no revenue share. Prices shown on the site are indicative; the binding quote is confirmed in writing before the service begins.

2.4 Guarantees and results

Replacement: under both plans, if a delivered unit does not meet the qualification criteria agreed in writing with the CLIENT, it is replaced at no additional cost. 2X Guarantee: DRAKGEN guarantees a minimum return equal to twice the amount invested in the pack, measured against the opportunities the CLIENT itself marks as advanced in its CRM and valued using the average fee per transaction declared by the CLIENT before start. If that threshold has not been reached once the pack is exhausted, DRAKGEN delivers additional units at no cost until it is. The guarantee requires the CLIENT to contact each delivered unit within 5 minutes and document follow-up in its CRM. It is a guarantee of means and additional volume, not a promise of economic outcome: DRAKGEN does not guarantee signed transactions or specific revenue.

2.5 Indicative estimates

The figures shown by the ROI calculator and any other estimate on the site are illustrative, based on data entered by the user, and do not constitute a promise or guarantee of results.

2.6 Client obligations

The client agrees to maintain the capacity to respond to and manage delivered meetings (ideally within 24 hours) and to handle buyer data in accordance with applicable data protection law.

2.7 Limitation of liability

To the extent permitted by law, DRAKGEN's liability is limited to the amount of units actually invoiced. DRAKGEN is not liable for indirect damages or loss of profit.

2.8 Governing law and amendments

The relationship is governed by the law applicable to DRAK-MA LLC, without prejudice to any mandatory rights the client may have under the law of their own country. DRAKGEN may update these terms; the version published on this site is always the one in force.

03 · Privacy Policy

PERSONAL DATA PROCESSING

3.1 Data controller

DRAK-MA LLC (Wyoming, USA) is the controller responsible for data collected through this site. Privacy contact: privacidad@drak-ma.com.

3.2 Data we process

• —Identification and contact data provided via forms and bookings.
• —Professional data of the intermediation firm.
• —Browsing, device and cookie data.

3.3 Purposes and legal basis

We process data to manage requests and meetings, deliver and qualify the service, send commercial communications and improve the site. The legal bases are user consent, performance of a contract or pre-contractual steps, legitimate interest, and compliance with legal obligations.

3.4 Recipients and international transfers

To deliver the service we use technology providers acting as data processors, including Meta Platforms, Google, HighLevel (GoHighLevel) and leaddistro.io. Some of these providers may involve international data transfers, carried out with the appropriate safeguards required by applicable law (e.g. standard contractual clauses).

3.5 Retention

We retain data for as long as the relationship lasts and, afterward, for the periods legally required.

3.6 User rights

You may exercise your rights of access, rectification, erasure, objection, restriction and portability, and withdraw consent at any time, by writing to privacidad@drak-ma.com. If you are located in a jurisdiction with a data protection authority, you have the right to lodge a complaint with the competent authority.

3.7 Cookies and security

The site may use its own and third-party cookies for technical, analytical and advertising purposes; you can manage them from your browser settings. DRAKGEN applies reasonable technical and organizational measures to protect the data processed.

04 · About DRAKGEN

COMPANY DETAILS

DRAKGEN is an international system for acquiring qualified home buyers for mortgage intermediation firms. It combines direct-response marketing, automation and AI agents to deliver confirmed meetings, not cold leads.